Immunotherapy can be offered as a treatment option to patients with advanced lung cancer, either upfront, or in cases where previous treatment such as surgery, chemotherapy, and radiation have been used. It may also be offered to patients whose tumour has a higher expression ...
A multidisciplinary panel of specialists from Parkway Cancer Centre (PCC) gathered at a seminar on Understanding Cancer: Advances in Treatment & Care to share insights on the latest advances in the field. As doctors and allied health professionals took turns to present major ...
Adding nivolumab to adjuvant chemotherapy in resected stage III gastric cancer failed to improve 3-year disease-free survival over chemotherapy alone. Ipilimumab and nivolumab as preoperative therapy in MSI-high gastric cancer resulted in a high rate of pathologic complete response. Trastuzumab added to...
In small-cell lung cancer, the use of prophylactic cranial radiation has increased survival rates and quality of life in both limited and extensive stage disease. This review will address these recent advances in the treatment of lung cancer. 展开 ...
Conference|WCLC: World Conference on Lung Cancer The 2024 World Conference on Lung Cancer (WCLC), meeting in San Diego, California, from September 7 to 10, 2024, will feature practice-changing data and discussion in the lung cancer space....
The use of immune checkpoint inhibitors, particularly with antibodies directed against programmed cell death 1 protein (PD-1) or its ligand (PD-L1), has led to important advances in the treatment of metastatic urothelial cancer and been tested in the early stages of bladder cancer. However, onl...
beam therapy, which is a highly precise radiation treatment that destroys cancer cells while sparing surrounding healthy tissue. Proton therapy has been found to cause fewer side effects. Though this technology was approved decades ago, refinements continue to improve its usefulness in many tumor ...
Cancer immunotherapy has revolutionized cancer treatment. In contrast to chemotherapies and other treatments that directly destroy cancer cells, these medications aim to boost antitumor immune responses with fewer side effects [4]. Various strategies are employed by tumors to evade the immune system, ...
Despite the progress in cancer diagnostic and treatment, the problem of cancer metastasis is still unsolved. Approximately 90% of cancer patients die due to the metastatic disease progression. It is assumed that elucidation of the molecular mechanisms associated with cancer cell spread to the … ...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is most frequently detected at advanced stages, limiting treatment options to systemic chemotherapy with modest clinical responses. Here, we review recent advances in targeted therapy and immunotherapy for treating subtypes of PDAC with ...